France's Pharnext Undone By Placebo Effect

 
• By Kevin Grogan

The Paris-based biotech's Charcot-Marie-Tooth disease drug falls short in Phase III.

Man Holding Up Falling Blocks
• Source: Shutterstock

More from Clinical Trials

More from R&D